Bloomberg Novartis AG raised its earnings forecast for the third time this year as new drugs including gene therapy Zolgensma got off to a strong start. Sales of the world’s most expensive drug beat analysts’ estimates with more than 100 children treated since Zolgensma’s May approval. Novartis said plans are in place covering about 90% of commercial patients and about ...

At a gathering of military and intelligence veterans, one topic shrouded the room: President Trump’s decision to abandon Kurdish fighters in Syria who had fought and died to help America destroy the IS. “It’s a dagger to the heart to walk away from people who shed blood for us,” one former top CIA official who attended the black-tie dinner told ...

Apple Inc.’s suppliers have walked a tightrope for a long time. They try very hard to get their products into the iPhone because it can mean a massive increase in sales. But they must proceed with care, as doing so risks yoking their business to the whims of the Silicon Valley giant’s famously capricious supply chain operations. When iPhone sales ...